Bio-thera Solutions, Ltd. Class ASSE: 688177

"Bio-Thera Solutions, Ltd."Announcement on Attending the 2026 Collective Reception Day for Investors in Guangdong Jurisdiction and Interim Performance Briefing for Listed Companies in the Jurisdiction

Sep 8, 2026 · Issued by Bio-thera Solutions, Ltd. Class A via Shanghai Stock Exchange

Announcement on Attending the 2026 Collective Reception Day for Investors in Guangdong Jurisdiction and Interim Performance Briefing for Listed Companies in the Jurisdiction

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis

Earlier from Bio-thera Solutions, Ltd. Class A

"Bio-Thera Solutions, Ltd."Announcement on Resignation of the Chief Financial Officer and Designation of the Chairman and the General Manager to Act as the Chief Financial OfficerSep 2
"Bio-Thera Solutions, Ltd."Special Report on the Deposit, Management and Actual Use of Raised Funds for the First Half of 2026Aug 26
"Bio-Thera Solutions, Ltd."Announcement on Voluntary Disclosure of the Receipt of the Approval Notice for Supplementary Application for Bevacizumab Injection (POBEVCY)Aug 21
"Bio-Thera Solutions, Ltd."Announcement on Voluntary Disclosure Regarding the Progress of Receipt of Milestone Payment under the License and Commercialization Agreement with Intas Pharmaceuticals Ltd. for BAT2506 (Golimumab) InjectionJul 30

All Bio-thera Solutions, Ltd. Class A news releases